Hide Board Information

Show Board Information

Apogee Technology Inc. ATCSE

Board Mod: Add me as mod

Asst Mods:

Last Post: 01/17/2012 12:53:58 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

Apogee Technology Inc. (OTCMRKTS: ATCSE) Stock Message Board

1. ATCSE Company Profile

    

2. ATCSE Time & Sales

    

3. ATCSE Recent News

    

4. ATCSE Filings

    

5. ATCSE Financials

    

6. ATCSE Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

Be the first to post on Apogee Technology Inc. ATCSE

Recent Articles

• Candel Therapeutics Secures $130 Million Loan for Clinical Trials
• HEINEKEN's Office Transformation: Fueling Future Growth Strategies
• Pre-Market Stock Declines: Orion, Nio, and Others Drop Significantly
• Healthcare Logistics Errors: Hidden Costs and Solutions Revealed
• Kong Inc. Celebrates Innovators at Annual Partner Awards
• Wall Street Analysts Adjust PNC Financial Predictions for Earnings
• Walker River Resources Unveils Impressive Gold Drill Results
• Madison Street Capital Successfully Guides Beaumont Electric's Sale
• Candel Therapeutics Secures $130 Million Loan for Cancer Trials
• Wipfli's 21st Annual Community Day: Uniting for a Cause
• Unlock Monthly Income with Bank of America Dividends
• North Shore Uranium Wraps Up Falcon Project Prospecting Work
• Empowering Future Technicians: The Sonic Impact Scholarship
• RPM International Upgrade: An Analyst's Optimistic Viewpoint
• Understanding the Rapid Growth of the Global Sensor Market
• Investor Concerns Rise Over SelectQuote, Inc. Lawsuit
• Glide Identity Launches Innovative Anti-Phishing Solutions
• Mutuum Finance Surpasses $17 Million in Prelude to Launch
• Exciting Opportunities Await Artists at Frederick Arts Council
• Coveo Expands AI Agent Capabilities with Custom Actions
• Krystal Biotech Celebrates FDA Designation Boosting KB801 Development
• Clear Channel Outdoor and Blood Cancer United Innovate Awareness Campaign
• Integral Metals Enhances Private Placement Offering to C$3M
• Lexicon Pharmaceuticals Advances Pilavapadin for Diabetic Pain Relief
• TransCode Therapeutics Reports Promising Phase 1a Study Results
• Telitacicept Shows Promising Results in Sjögren's Disease Study
• Sina Corporation Investors: Important Class Action Information
• Corbus Pharmaceuticals Unveils Key Data for CRB-701 Trial
• Oracle Cloud Infrastructure: Empowering Businesses with AI Solutions
• Provident Bank Welcomes New EVP, Retail Banking Director
• Predictive Oncology Expands Leadership with Key Appointments
• Talkspace Announces Q3 2025 Results and Upcoming Call Details
• Enviri Corporation Set to Reveal Third Quarter Results Soon
• Copper Quest Updates Drilling Efforts and Option Agreement Changes
• CareCloud Set to Reveal Third Quarter Results Soon
• Exploring IoT Trends: Insights from Verizon's Business Survey
• Amarin and HLS Therapeutics Share Key Cardiovascular Data Insights
• Opus Genetics Prepares for Genetic Medicines Conference Update
• MISTRAS Group Innovates with Wireless Monitoring Solutions for Steel
• Just For Laughs and Stingray Team Up for Global Comedy Initiative
• Chris Fozard Joins Aventis Energy as Technical Advisor
• Myriad Genetics Expands Carrier Screening with New Gene Additions
• Maxus Mining Completes Significant Exploration Programs in 2025
• Milestone Scientific's Strategic Advances Under Eric Hines
• Landstar System Prepares for Q3 Earnings Announcement Soon
• Crypto Market Sees Significant Declines with BTC Under $112k
• TeraWulf Inc. Seeks $3.2 Billion in Senior Secured Notes Offering
• Milestone Scientific's Growth Strategy Under New Leadership
• Analysts Downgrade Key Stocks: Insights for Investors
• Scott Bessent Shares Concerns About IPO Delays Amid Shutdown